Bachem H-Arg-Gly-Asp-Cys-OH
H-Arg-Gly-Asp-Cys-OH Trifluoroacetate, 109292-46-8, C15H27N7O7S, Mr 449.49, 25mg. RGDC, R-G-D-C. Surfaces modified with RGDC were shown to be effective for osteoblast binding and proliferation. RGDC binds via its sulfhydryl moiety to gold particles and gold-coated implants increasing the biocompatibility of the latter. The surface of titanium implants has to be modified beforehand to allow covalent S binding.